Corey E - Search Results

1

Contribution of Adrenal Glands to Intratumor Androgens and Growth of Castration-Resistant Prostate Cancer.

Mostaghel EA, Zhang A, Hernandez S, Marck BT, Zhang X, Tamae D, Biehl HE, Tretiakova M, Bartlett J, Burns J, Dumpit R, Ang L, Matsumoto AM, Penning TM, Balk SP, Morrissey C, Corey E, True LD, Nelson PS. Mostaghel EA, et al. Among authors: corey e. Clin Cancer Res. 2019 Jan 1;25(1):426-439. doi: 10.1158/1078-0432.CCR-18-1431. Epub 2018 Sep 4. Clin Cancer Res. 2019. PMID: 30181386 Free PMC article.

2

Prostatic cell lineage markers: emergence of BCL2+ cells of human prostate cancer xenograft LuCaP 23 following castration.

Liu AY, Corey E, Bladou F, Lange PH, Vessella RL. Liu AY, et al. Among authors: corey e. Int J Cancer. 1996 Jan 3;65(1):85-9. doi: 10.1002/(SICI)1097-0215(19960103)65:1<85::AID-IJC15>3.0.CO;2-H. Int J Cancer. 1996. PMID: 8543402

3

Identification of differentially expressed prostate genes: increased expression of transcription factor ETS-2 in prostate cancer.

Liu AY, Corey E, Vessella RL, Lange PH, True LD, Huang GM, Nelson PS, Hood L. Liu AY, et al. Among authors: corey e. Prostate. 1997 Feb 15;30(3):145-53. doi: 10.1002/(sici)1097-0045(19970215)30:3<145::aid-pros1>3.0.co;2-l. Prostate. 1997. PMID: 9122038

4

Osteoprotegerin and rank ligand expression in prostate cancer.

Brown JM, Corey E, Lee ZD, True LD, Yun TJ, Tondravi M, Vessella RL. Brown JM, et al. Among authors: corey e. Urology. 2001 Apr;57(4):611-6. doi: 10.1016/s0090-4295(00)01122-5. Urology. 2001. PMID: 11306358

5

Serum osteoprotegerin levels are increased in patients with advanced prostate cancer.

Brown JM, Vessella RL, Kostenuik PJ, Dunstan CR, Lange PH, Corey E. Brown JM, et al. Among authors: corey e. Clin Cancer Res. 2001 Oct;7(10):2977-83. Clin Cancer Res. 2001. PMID: 11595685

6

Inhibition of androgen-independent growth of prostate cancer xenografts by 17beta-estradiol.

Corey E, Quinn JE, Emond MJ, Buhler KR, Brown LG, Vessella RL. Corey E, et al. Clin Cancer Res. 2002 Apr;8(4):1003-7. Clin Cancer Res. 2002. PMID: 11948106

7

Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer.

Corey E, Brown LG, Quinn JE, Poot M, Roudier MP, Higano CS, Vessella RL. Corey E, et al. Clin Cancer Res. 2003 Jan;9(1):295-306. Clin Cancer Res. 2003. PMID: 12538482

8

Cathepsin K mRNA and protein expression in prostate cancer progression.

Brubaker KD, Vessella RL, True LD, Thomas R, Corey E. Brubaker KD, et al. Among authors: corey e. J Bone Miner Res. 2003 Feb;18(2):222-30. doi: 10.1359/jbmr.2003.18.2.222. J Bone Miner Res. 2003. PMID: 12568399 Free article.

9

Expression of the human cachexia-associated protein (HCAP) in prostate cancer and in a prostate cancer animal model of cachexia.

Wang Z, Corey E, Hass GM, Higano CS, True LD, Wallace D Jr, Tisdale MJ, Vessella RL. Wang Z, et al. Among authors: corey e. Int J Cancer. 2003 May 20;105(1):123-9. doi: 10.1002/ijc.11035. Int J Cancer. 2003. PMID: 12672042

10

LuCaP 35: a new model of prostate cancer progression to androgen independence.

Corey E, Quinn JE, Buhler KR, Nelson PS, Macoska JA, True LD, Vessella RL. Corey E, et al. Prostate. 2003 Jun 1;55(4):239-46. doi: 10.1002/pros.10198. Prostate. 2003. PMID: 12712403

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

653 results

Search Page

Filters